AI advances in the liver disease field
The AI Revolution in Liver Disease: From Diagnosis to Drug Development Metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), is a growing public health concern. Affecting an estimated 13 million American adults, according to the American Liver Foundation, MASH represents the advanced inflammatory form of metabolic dysfunction-associated steatotic liver disease (MASLD), where fat … Read more